Middle East And Africa Cell Manufacturing Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2021 –2028 |
 Market Size (Base Year) |
USD 11,076.78 Million |
 Market Size (Forecast Year) |
USD 23,505.08 Million |
 CAGR |
% |
| Major Markets Players |
Middle East and Africa Stem Cell Manufacturing Market, By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (South Africa, Saudi Arabia, UAE, Israel, Egypt & Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Middle East and Africa Cell Manufacturing Market
The stem cell manufacturing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.1% in the forecast period of 2021 to 2028 and is expected to reach USD 23,505.08 million by 2028 from USD 11,076.78 million in 2020. The rising prevalence of cancer and stem cell transplant, growth of novel technological advancements for stem cell transplant is likely to be the major drivers which propel the demand of the market in the forecast period.
Stem cells are body’s raw material which can differentiate into variety of cells. It means cells from which all other cells with specialized functions are generated. Stem Cell therapies are defined as treatment for medical condition which involves the use of any type of human stem cells including embryonic stem cells, adult stem cells for allogenic and autologous therapies.
The advent of stem cell research revealed the therapeutic potential of stem cells and derivatives. The successful manufacturing of stem cells and their derivatives is giving positive impact in healthcare arena. These stem cell products are used to restore the function of damaged tissue and organ and to develop stem cell based cellular therapies for the treatment of cancer, haematological disorder, genetic disorder, autoimmune and inflammatory diseases.
Increasing research & development by key industry players for development of innovative products, support by government, and growing adoption of stem cells are driving the growth of the market. Advanced methodologies present in the field are also propelling the growth of the global stem cell manufacturing market. However, high cost of therapies, availability of alterntives for tumor treatment may restrain the market. The presence of large number of pipelines products along with strategic initiatives taken by market players are acting as opportunity for the market. Lack of skilled professional may act as challenge for the market.
The global stem cell manufacturing market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Stem Cell Manufacturing Market Scope and Market Size
The stem cell manufacturing market is categorized into four notable segments which are based on products, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of products, stem cell manufacturing market is segmented into stem cell lines, instruments, consumables & kits. In 2021, consumables & kits segment is expected to dominate the market due to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies
- On the basis of application, stem cell manufacturing market is segmented into research applications, clinical applications, cell and tissue banking and others. In 2021, research applications segment is expected to dominate market because due to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.
- On the basis of end user, stem cell manufacturing market is segmented into biotechnology & pharmaceutical companies, research institutes and academic institutes, cell banks and tissue banks, hospital & surgical centers and others. In 2021, pharmaceutical & biotechnology companies segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by pharma and biotech companies to expand their capabilities in stem cell research.
- On the basis of distribution channel,stem cell manufacturing market is segmented into direct sales and third party distributors. In 2021, direct sales segment is expected to dominate the market because of large number of players in the market.
Stem Cell Manufacturing Market Country Level Analysis
Thestem cell manufacturing market is analysed and market size information is provided by products, application, end user and distribution channel.
The countries covered in theMiddle East and Africastem cell manufacturing market report are South Africa, Saudi Arabia, UAE, Israel, Egypt, Kuwait and rest of Middle East and Africa in Middle East and Africa (MEA).
South Africa is expected to dominate in the market in the Middle East & Africa market. South Africa is one of the leading countries to inculcate the stem cell manufacturing market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
The Growing Adoption of Stem Cell Therapy along with Public-Private Funding are Creating Opportunities in the Global Stem Cell Manufacturing Market
The stem cell manufacturing market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the ELISpot and FluorSpot assayand changes in regulatory scenarios with their support for the ELISpot and FluorSpot assay market. The data is available for historic period 2019 to 2020.
Competitive Landscape andStem Cell Manufacturing Market Share Analysis
The stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the stem cell manufacturing market.
The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Sartorius AG, STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.
The strategic initiatives by market players along with new technological advancements for stem cell manufacturing is bridging the gap for various treatments.
For instance,
- In June 2021, REPROCELL Inc. announced that it has opened new seed iPSC manufacture suite to meet the increasing demand of Ipsc-derived master cell banks. This will help the company to address the rising demand and to grow in coming years.
- In June 2021, Catalent Inc. announced that is has acquired RheinCell Therapeuics which is a manufaxcturer of human induced pluripotent stem cells. This will help the company to build up the company’s existing custom cell herapy process development.
- In June 2021, Bio-Techne announced that is has enhanced its gene engineering and cell and gene therapy manufacturing capability. This will help the company to further expand its business.
Collaboration, joint ventures, and other strategies by the market player is enhancing the company market in the stem cell manufacturing market, which also provides the benefit for the organization to improve their offering for stem cell manufacturing market.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
